Cargando…
Vogt-Koyanagi-Harada Disease-Like Uveitis during Nivolumab (Anti-PD-1 Antibody) Treatment for Metastatic Cutaneous Malignant Melanoma
Nivolumab is an anti-programmed cell death protein 1 monoclonal antibody that is used to treat metastatic cutaneous malignant melanoma. Although bilateral uveitis has been reported as a side effect of nivolumab administration, there are few reports of Vogt-Koyanagi-Harada disease (VKH)-like uveitis....
Autores principales: | Obata, Shumpei, Saishin, Yoshitsugu, Teramura, Kazuya, Ohji, Masahito |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
S. Karger AG
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6489058/ https://www.ncbi.nlm.nih.gov/pubmed/31097947 http://dx.doi.org/10.1159/000496682 |
Ejemplares similares
-
Vogt‐Koyanagi‐Harada disease‐like posterior uveitis in the course of nivolumab (anti‐PD‐1 antibody), interposed by vemurafenib (BRAF inhibitor), for metastatic cutaneous malignant melanoma
por: Matsuo, Toshihiko, et al.
Publicado: (2017) -
Commentary: Appraisal of histopathological correlations in Vogt-Koyanagi-Harada uveitis
por: Murugan, Sivaraman Bala
Publicado: (2019) -
A Case of Vogt-Koyanagi-Harada Disease-Like Uveitis Induced by Nivolumab and Ipilimumab Combination Therapy
por: Minami, Keisuke, et al.
Publicado: (2021) -
Intravitreal methotrexate and fluocinolone acetonide implantation for Vogt-Koyanagi-Harada uveitis
por: Park, Jong G., et al.
Publicado: (2020) -
Tuberculous Posterior Sclero-Uveitis with Features of Vogt-Koyanagi-Harada Uveitis: An Unusual Case
por: Kalogeropoulos, Dimitrios, et al.
Publicado: (2017)